India-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus Milestones

Sun Pharmaceutical Industries Limited, India’s top pharmaceutical company, has agreed to acquire Concert Pharmaceuticals Inc (NASDAQ: CNCE) for an upfront payment of $8.00 per share, or $576 mil...